TWD 72.7
(-0.41%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.09 Billion TWD | 5.47% |
2022 | 1.03 Billion TWD | 8.81% |
2021 | 955.01 Million TWD | -14.0% |
2020 | 1.11 Billion TWD | 29.33% |
2019 | 858.68 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.11 Billion TWD | 2.22% |
2024 Q1 | 1.09 Billion TWD | -0.37% |
2023 Q4 | 1.09 Billion TWD | -18.64% |
2023 FY | 1.09 Billion TWD | 5.47% |
2023 Q1 | 1.02 Billion TWD | -1.05% |
2023 Q3 | 1.34 Billion TWD | 28.41% |
2023 Q2 | 1.04 Billion TWD | 2.02% |
2022 Q4 | 1.03 Billion TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | -82.211% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | -605.094% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -2498.838% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 31.427% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | -0.014% |
Center Laboratories, Inc. | 269.22 Million TWD | -307.074% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -1345.929% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | -368.413% |
InnoPharmax Inc. | 22.24 Million TWD | -4827.195% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | -689.554% |
Excelsior Biopharma Inc. | 217.28 Million TWD | -404.396% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -1035.529% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -764.325% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -3686.47% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | -286.089% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -846.945% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -10779.055% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -1858.813% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -825.678% |